Showing results (1611-1620 of 6,509) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 1, 1992
In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cellsB Gonen, O Kahana, I P WitzCancer Immunology, Immunotherapy : CII|January 1, 1990
A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patientsF Boue, Z Pastran, M Spielmann, et al.Cancer Immunology, Immunotherapy : CII|September 8, 2010
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancersMelissa A Geller, Sarah Cooley, Peter A Argenta, et al.Cancer Immunology, Immunotherapy : CII|December 21, 2010
Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assayStefania Pacini, Gabriele Morucci, Tiziana Punzi, et al.Cancer Immunology, Immunotherapy : CII|February 18, 2011
TH1 predominance is associated with improved survival in pediatric medulloblastoma patientsVerena Wiegering, Matthias Eyrich, Stefan Rutkowski, et al.Cancer Immunology, Immunotherapy : CII|February 19, 2011
An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicityMingkai Xu, Xiaogang Wang, Yongming Cai, et al.Cancer Immunology, Immunotherapy : CII|October 26, 2010
Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapyMatthias Wölfl, Katharina Merker, Henner Morbach, et al.Cancer Immunology, Immunotherapy : CII|October 28, 2010
Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancerMotoyoshi Kurosaki, Shigetoshi Horiguchi, Kazuki Yamasaki, et al.Cancer Immunology, Immunotherapy : CII|January 18, 2011
Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemiaJianqiang Zhao, Aili He, Wanggang Zhang, et al.Cancer Immunology, Immunotherapy : CII|January 18, 2011
Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma modelKevin Durgan, Mohamed Ali, Paul Warner, et al.Pageof 651